2020
Tittle | Author | Journal | Impact factor | Ranking |
Integration of metagenomics-metabolomics reveals specific signatures and functions of airway microbiota in mite-sensitized childhood asthma | Chih-Yung Chiu, Hsin-Cheng Chou, Lun-Ching Chang, Wen-Lang Fan, Michael Cong Vinh Dinh, Yu-Lun Kuo, Wen-Hung Chung, Hsin-Chih Lai, Wen-Ping Hsieh, Shih-Chi Su* | Allergy. 2020 Nov;75(11):2846-2857. | 8.706 |
Allergy (2/28=7.14%) |
Microbiome technology empowers the development of traditional Chinese medicine | Hongtao Liu, Junping Zheng, Hsin-Chih Lai, Baifei Hu, Lin Zhu, Elaine Lai-Han Leung* & Hong Wei* | Science China-Life Sciences. 2020 Nov ;63(11):1759-1761. | 4.611 |
Biology (13/93=14%) |
Identification of hsa-miR-1275 as a Novel Biomarker Targeting MECP2 for Human Epilepsy of Unknown Etiology | Ye Zhao, Congxia Lu, Huiling Wang, Qing Lin, Liangliang Cai, Fanrong Meng, Enque Biniam Tesfaye, Hsin-Chih Lai, Chi-Meng Tzeng* | Molecular Therapy-Methods & Clinical Development. 2020 Oct; 19:398-410. | 4.875 |
Medicine, Research & Experimental (34/139=24.46%) |
Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction | I-Wen Wu, Chin-Chan Lee, Heng-Jung Hsu, Chiao-Yin Sun , Yuen-Chan Chen, Kai-Jie Yang, Chi-Wei Yang, Wen-Hun Chung, Hsin-Chih Lai, Lun-Ching Chang* ,and Shih-Chi Su* | Nutrients. 2020 Sep 12; 12(9):E2799. | 4.546 | Nutrition & Dietetics (17/89=19.1%) |
Role of gut microbiota in identification of novel TCM-derived active metabolites | Tzu-Lung Lin, Chia-Chen Lu, Wei-Fan Lai, Ting-Shu Wu, Jang-Jih Lu, Young-Mao Chen, Chi-Meng Tzeng, Hong-Tao Liu, Hong Wei, Hsin-Chih Lai* | Protein & Cell. 2020 Sep 15 | 10.164 |
Cell Biology (19/195=9.74%) |
Roles of Gut Microbiota and Sera Metabolomics in Amelioration of Diabetes and Metabolic Syndrome by Bariatric Surgery | Tzu-Lung Lin , Chia-Chen Lu , Wei-Fan Lai, Hsin-Chih Lai* | J Biomed Lab Sci. 2020 Sep. Vol. 32, No.3 | ||
Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial lung disease | Chin-Chung Shu, Ming-Fang Wu, Sheng-Wei Pan, Ting-Shu Wu*, Hsin-Chih Lai*, Meng-Chih Lin | Journal of the Formosan Medical Association. 2020 May 22;S0929-6646(20)30174-1 | 3.008 |
Medicine, General & Internal (42/165=25.46%) |
Like Cures Like: Pharmacological Activity of Anti-Inflammatory Lipopolysaccharides From Gut Microbiome | Tzu-Lung Lin, Chin-Chung Shu, Young-Mao Chen, Jang-Jih Lu, Ting-Shu Wu, Wei-Fan Lai, Chi-Meng Tzeng, Hsin-Chih Lai, Chia-Chen Lu | Frontiers in Pharmacology.2020 Apr 30;11:554. | 4.225 |
Pharmacology & Pharmacy (52/270=29.26%) |
Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease | I-Wen Wu, Sheng-Siang Gao, Hsin-Cheng Chou, Huang-Yu Yang, Lun-Ching Chang, Yu-Lun Kuo, Michael Cong Vinh Dinh, Wen-Hung Chung, Chi-Wei Yang, Hsin-Chih Lai, Wen-Ping Hsieh, Shih-Chi Su | Theranostics. 2020; 10(12): 5398-5411 | 8.579 |
Medicine, Research & Experimental (10/138=7.25% ) |
Relationships Among and Predictive Values of Obesity, Inflammation Markers, and Disease Severity in Pediatric Patients with Obstructive Sleep Apnea Before and After Adenotonsillectomy | Hai-Hua Chuang, Chung-Guei Huang, Li-Pang Chuang, Yu-Shu Huang, Ning-Hung Chen, Hsueh-Yu Li, Tuan-Jen Fang, Jen-Fu Hsu, Hsin-Chih Lai, Jau-Yuan Chen and Li-Ang Lee* | Journal of Clinical Medicine. 2020 Feb; 9(2): 579. | 5.688 |
Medicine General Internal (36/165=21.82%) |
Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study. | I-Wen Wu, Chan-Yu Lin, Lun-Ching Chang, Chin-Chan Lee, Chih-Yung Chiu, Heng-Jung Hsu, Chiao-Yin Sun, Yuen-Chan Chen, Yu-Lun Kuo, Chi-Wei Yang, Sheng-Siang Gao, Wen-Ping Hsieh, Wen-Hung Chung, Hsin-Chih Lai, Shih-Chi Su* | International Journal of Biological Sciences. 2020 Jan 1;16(3):420-434. | 4.858 | Biochemistry & Molecular Biology (65/297=21.89%) |